Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume |
|---|---|---|---|---|
| RXH | Rewardle Holding Ltd | 0.022 | 69 | 5474918 |
| PHL | Propell Holdings Ltd | 0.155 | 58 | 5068482 |
| VIC | Victory Mines Ltd | 0.002 | 33 | 5750500 |
| CCE | Carnegie Cln Energy | 0.0025 | 25 | 716608 |
| NTL | New Talisman Gold | 0.0025 | 25 | 16755653 |
| TER | Terracom Ltd | 0.195 | 18 | 1059333 |
| ARE | Argonaut Resources | 0.007 | 17 | 850000 |
| TMK | Tamaska Oil Gas Ltd | 0.008 | 14 | 650000 |
| DLC | Delecta Limited | 0.0125 | 14 | 8619325 |
| KOV | Korvest Ltd | 6.35 | 13 | 14504 |
Rewardle Holdings (ASX:RXH) unveiled a deal that would see it earn equity in BNPL firm SplitPay.
Fintech Propell (ASX:PHL) unveiled a partnership with Square.
After a week’s suspension for late lodgement of its report, coal company TerraCom (ASX:TER) re-entered the bourse and confirmed to its shareholders it had completed a refinance agreement.
Korvest (ASX:KOV) rose off the back of updated profit guidance.
| Code | Company | Price | % | Volume |
|---|---|---|---|---|
| SE1 | Sensera Ltd | 0.023 | -36 | 9385769 |
| CGB | Cann Global Limited | 0.004 | -20 | 1000000 |
| DCX | Discovex Res Ltd | 0.004 | -20 | 21000 |
| AYM | Australia United Min | 0.008 | -11 | 11111 |
| CVS | Cervantes Corp Ltd | 0.009 | -10 | 3158500 |
| LME | Limeade Inc. | 0.555 | -10 | 101099 |
| PDZ | Prairie Mining Ltd | 0.32 | -9 | 129789 |
| EML | EML Payments Ltd | 3.39 | -8 | 3497415 |
| RED | Red 5 Limited | 0.245 | -8 | 952032 |
| RF1 | Regal Invest Fund | 3.98 | -7 | 27199 |
Sensera (ASX:SE1) plunged after telling shareholders it was not able to go ahead with its plans to provide rapid COVID testing – at least at the volume that would make it commercially viable.